+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atopic Dermatitis Market - Global Forecast 2026-2032- Product Image
Atopic Dermatitis Market - Global Forecast 2026-2032- Product Image
New

Atopic Dermatitis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977937
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The atopic dermatitis market presents both new opportunities and operational demands for senior decision-makers navigating shifting therapeutic practices, evolving stakeholder needs, and unpredictable supply chain dynamics. Strategic, evidence-based leadership is essential as this landscape continues to mature and diversify.

Market Snapshot

The atopic dermatitis market grew from USD 22.02 billion in 2025 to USD 23.30 billion in 2026. Forecasts indicate steady expansion at a 6.14% CAGR, with expectations to reach USD 33.44 billion by 2032. This upward trend is driven by improved rates of diagnosis, the growing array of therapeutic options, and increased demand for innovative treatments across all patient segments and disease severities. These market signals point to an increasingly competitive and resilient sector, where strategic differentiation remains crucial for long-term positioning.

Scope & Segmentation of the Atopic Dermatitis Market

This report delivers a comprehensive analysis of the atopic dermatitis market, highlighting critical segmentation drivers and supporting informed strategies for leadership teams. Core segmentation factors include:

  • Product Classes: Topical corticosteroids, calcineurin inhibitors, biologic monoclonal antibodies, Janus kinase inhibitors, antibiotics, antivirals, antifungals, antihistamines, and phototherapy modalities such as narrowband UVB and excimer laser technologies.
  • Administration Routes: Topical (creams, ointments, lotions), oral (capsules, tablets), and parenteral options (intramuscular, intravenous) aligned to disease intensity and clinical oversight.
  • Severity Tiers: Mild cases typically respond well to topical therapies and patient education, moderate cases may require systemic agents or adjunctive physical interventions, while severe presentations demand coordinated multi-specialty care and nuanced reimbursement strategies.
  • Patient Cohorts: Pediatric and adult populations, each requiring tailored formulations, distinct safety monitoring, and different regulatory considerations.
  • Distribution Channels: Hospital pharmacies, online platforms, and retail outlets supplying both prescription and over-the-counter products.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each assessed by clinical adoption patterns, reimbursement policies, and local supply chain practices.
  • Technological Developments: Integrated digital care platforms, novel delivery vehicles, and teledermatology tools that support remote patient management and broaden market access.

Key Takeaways for Senior Decision-Makers

  • Innovation in product pipelines and diversification in care modalities require executive-level strategies to manage operational complexity and risk across markets.
  • Molecularly targeted treatments are redefining clinical standards, supporting stepwise management, and shifting expectations for durable disease control beyond traditional immunosuppressants.
  • Developments in topical treatment technologies are facilitating safer long-term maintenance strategies, expanding chronic care possibilities and reinforcing patient-driven approaches.
  • Payer behaviors and reimbursement timelines are increasingly linked to real-world clinical outcomes and patient adherence, necessitating strong data-driven value communication in negotiations.
  • Appropriate alignment of product, patient segment, and treatment severity enhances both utilization and procurement strategy, mitigating exposure to volatility in the supply chain.
  • Regional variations in clinical guidelines and localized manufacturing or distribution channels create significant differences in product adoption, strengthening the case for region-specific market strategies.

Tariff Impact on Market Access and Supply Chains

Evolving tariff structures and regulatory shifts impact overall landed costs for both finished therapies and essential active pharmaceutical ingredients. For manufacturers managing international sourcing, this often results in compressed margins and increased need for supply chain realignment—be it nearshoring, diversification of suppliers, or both. These adjustments cascade into procurement behaviors among hospitals and retail pharmacies, shaping contract landscapes and affecting how patients ultimately access care. To minimize disruption, leading organizations are employing methods such as strategic stockpiling, investing in domestic production facilities, and proactively evaluating therapeutic substitutions as contingency plans.

Methodology & Data Sources

This analysis combines evidence from peer-reviewed clinical publications, global regulatory filings, and international clinical trial registries with supply chain intelligence. Expert input from clinicians, payers, and industry leaders supplements quantitative data to ensure multidimensional market insights. Triangulation across sources validates all findings, maintaining transparency regarding assumptions and limitations.

Why This Report Matters

  • Delivers actionable intelligence by linking new therapeutic advances to practical commercial and operational strategies for executive teams.
  • Enables risk mitigation and operational planning with region-specific insights on regulatory, supply chain, and pricing challenges.
  • Supports competitive differentiation through detailed analysis of market segmentation, technology trends, and changing payer priorities.

Conclusion

The atopic dermatitis market is entering a period of added complexity, shaped by the emergence of new therapies, technologies, and evolving access pathways. Ongoing success will depend on agile, well-integrated approaches that balance clinical innovation with supply chain resilience and local market nuance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Atopic Dermatitis Market, by Product
8.1. Light Therapy
8.1.1. Excimer Laser Therapy
8.1.2. PUVA Therapy
8.1.3. UVB Therapy
8.2. Medication
8.2.1. Antibiotics, Antivirals or Antifungals
8.2.2. Antihistamines
8.2.3. Corticosteroid
8.2.4. Janus Kinase (JAK) Inhibitors
8.2.5. Monoclonal Antibodies
8.2.6. Pimecrolimus or Tacrolimus
9. Atopic Dermatitis Market, by Mode Of Administration
9.1. Oral Administration
9.1.1. Capsules
9.1.2. Tablets
9.2. Parenteral Administration
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Topical Administration
9.3.1. Cream
9.3.2. Lotion
9.3.3. Ointment
10. Atopic Dermatitis Market, by Severity Level
10.1. Mild Atopic Dermatitis
10.2. Moderate Atopic Dermatitis
10.3. Severe Atopic Dermatitis
11. Atopic Dermatitis Market, by Patient Demographics
11.1. Adult Patients
11.2. Pediatric Patients
12. Atopic Dermatitis Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Online Pharmacies
12.3. Retail Pharmacies
13. Atopic Dermatitis Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Atopic Dermatitis Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Atopic Dermatitis Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Atopic Dermatitis Market
17. China Atopic Dermatitis Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Amgen Inc.
18.7. AstraZeneca PLC
18.8. Bausch Health Companies Inc.
18.9. Biofrontera AG
18.10. Bristol-Myers Squibb Company
18.11. Chugai Pharmaceutical Co., Ltd.
18.12. Daavlin Company
18.13. Eli Lilly and Company
18.14. F. Hoffmann-La Roche Ltd.
18.15. Galderma Holding SA
18.16. GlaxoSmithKline PLC
18.17. Incyte Corporation
18.18. Johnson & Johnson Services Inc.
18.19. LEO Pharma A/S
18.20. Maruho Co., Ltd
18.21. Novartis AG
18.22. Perrigo Company PLC
18.23. Pfizer, Inc.
18.24. Regeneron Pharmaceuticals, Inc
18.25. Sanofi SA
18.26. Solarc Systems Inc.
18.27. Teva Pharmaceutical Industries Ltd.
18.28. UCB S.A.
18.29. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY EXCIMER LASER THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY EXCIMER LASER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY EXCIMER LASER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PUVA THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PUVA THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PUVA THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY UVB THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY UVB THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY UVB THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIBIOTICS, ANTIVIRALS OR ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIBIOTICS, ANTIVIRALS OR ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIBIOTICS, ANTIVIRALS OR ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CORTICOSTEROID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CORTICOSTEROID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY JANUS KINASE (JAK) INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY JANUS KINASE (JAK) INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY JANUS KINASE (JAK) INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PIMECROLIMUS OR TACROLIMUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PIMECROLIMUS OR TACROLIMUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PIMECROLIMUS OR TACROLIMUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MILD ATOPIC DERMATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MILD ATOPIC DERMATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MILD ATOPIC DERMATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODERATE ATOPIC DERMATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODERATE ATOPIC DERMATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODERATE ATOPIC DERMATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERE ATOPIC DERMATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERE ATOPIC DERMATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERE ATOPIC DERMATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ADULT PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ADULT PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PEDIATRIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PEDIATRIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 146. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 153. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 168. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 169. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 170. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 172. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 173. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 174. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 175. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 191. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 192. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 193. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 194. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 195. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 197. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 198. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 199. ASEAN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. GCC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GCC ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 202. GCC ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 203. GCC ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 204. GCC ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. GCC ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 206. GCC ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 207. GCC ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 208. GCC ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 209. GCC ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 210. GCC ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. BRICS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. BRICS ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 224. BRICS ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 225. BRICS ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 226. BRICS ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 227. BRICS ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 228. BRICS ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 229. BRICS ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. BRICS ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 231. BRICS ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 232. BRICS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. G7 ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. G7 ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 235. G7 ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 236. G7 ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 237. G7 ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 238. G7 ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239. G7 ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 240. G7 ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 241. G7 ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 242. G7 ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 243. G7 ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. NATO ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. NATO ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 246. NATO ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 247. NATO ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 248. NATO ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. NATO ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 250. NATO ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 251. NATO ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 252. NATO ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 253. NATO ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 254. NATO ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 255. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 267. CHINA ATOPIC DERMATITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 268. CHINA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 269. CHINA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2032 (USD MILLION)
TABLE 270. CHINA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2032 (USD MILLION)
TABLE 271. CHINA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 272. CHINA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 273. CHINA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. CHINA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 275. CHINA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2032 (USD MILLION)
TABLE 276. CHINA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 277. CHINA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Atopic Dermatitis market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Biofrontera AG
  • Bristol-Myers Squibb Company
  • Chugai Pharmaceutical Co., Ltd.
  • Daavlin Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Galderma Holding SA
  • GlaxoSmithKline PLC
  • Incyte Corporation
  • Johnson & Johnson Services Inc.
  • LEO Pharma A/S
  • Maruho Co., Ltd
  • Novartis AG
  • Perrigo Company PLC
  • Pfizer, Inc.
  • Regeneron Pharmaceuticals, Inc
  • Sanofi SA
  • Solarc Systems Inc.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 23.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 33.44 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Atopic Dermatitis Market Report 2025 - Product Image

Atopic Dermatitis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Atopic Dermatitis Cream Market Report 2025 - Product Image

Atopic Dermatitis Cream Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Severe Atopic Dermatitis Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Severe Atopic Dermatitis Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Atopic Dermatitis Clinical Trials - Global Strategic Business Report - Product Image

Atopic Dermatitis Clinical Trials - Global Strategic Business Report

  • Report
  • 216 Pages
  • Global
From
Atopic Dermatitis Market Report and Forecast 2025-2034 - Product Image

Atopic Dermatitis Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.